Instil Financial Statements From 2010 to 2025
| TIL Stock | USD 27.99 2.05 7.90% |
Check Instil Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Instil Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Instil financial statements analysis is a perfect complement when working with Instil Bio Valuation or Volatility modules.
Check out the analysis of Instil Bio Correlation against competitors. Instil Bio Company Return On Equity Analysis
Instil Bio's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Instil Bio Return On Equity | -0.44 |
Most of Instil Bio's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Instil Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Instil Bio has a Return On Equity of -0.445. This is 98.14% lower than that of the Biotechnology sector and 98.78% lower than that of the Health Care industry. The return on equity for all United States stocks is 43.55% higher than that of the company.
Instil Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Instil Bio's current stock value. Our valuation model uses many indicators to compare Instil Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Instil Bio competition to find correlations between indicators driving Instil Bio's intrinsic value. More Info.Instil Bio is rated third in return on equity category among its peers. It is rated second in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Instil Bio by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Instil Bio Financial Statements
Instil Bio investors utilize fundamental indicators, such as revenue or net income, to predict how Instil Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company was incorporated in 2018 and is headquartered in Dallas, Texas. Instil Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 463 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Instil Bio Correlation against competitors. For more information on how to buy Instil Stock please use our How to buy in Instil Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instil Bio. If investors know Instil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instil Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Instil Bio is measured differently than its book value, which is the value of Instil that is recorded on the company's balance sheet. Investors also form their own opinion of Instil Bio's value that differs from its market value or its book value, called intrinsic value, which is Instil Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instil Bio's market value can be influenced by many factors that don't directly affect Instil Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instil Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instil Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instil Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.